MICHAEL F COLA
CIK 1188940 · Chief Executive Officer · last filed 2026-05-21
MICHAEL F COLA is a Chief Executive Officer who has filed 69 SEC Form 4 insider transactions across 9 companies since 2011. The most recent filing, for PHAT, was dated May 21, 2026. Across all open-market trades the lifetime net is +$1.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $893.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$893.3K
9
69
$1.36M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Director | 63,920 | $10.37 | $662.9K | $186.2K | 8 | 2026-05-21 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | — | $8.68 | — | $0 | 13 | 2025-07-31 |
| AVTX | Chief Executive Officer | — | $14.76 | — | $0 | 1 | 2021-10-04 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Chief Executive Officer | 175,746 | $2.93 | $514.9K | $250.0K | 9 | 2021-07-02 |
| Aevi Genomic Medicine, LLC (GNMX) Delisted | President and CEO | 2,267,859 | — | — | $424.6K | 7 | 2019-12-09 |
| VNDA | Director | 15,000 | $5.87 | $88.0K | $0 | 7 | 2019-06-17 |
| Aevi Genomic Medicine, LLC (MDGN) Delisted | President and CEO | — | — | — | $0 | 1 | 2016-04-19 |
| Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | President and CEO | 99,436 | — | — | $500.0K | 4 | 2015-10-08 |
| PATH | Director | 13,500 | $10.55 | $142.4K | $0 | 16 | 2014-01-03 |
Recent Filings
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | PHAT | Grant (A) | +24,122 | $0 | EDGAR |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-13 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | PHAT | Grant (A) | +10,500 | $0 | EDGAR |
| 2024-06-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | PHAT | Grant (A) | +10,500 | $0 | EDGAR |
| 2023-06-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-30 | PHAT | Grant (A) | +9,000 | $0 | EDGAR |
| 2022-06-17 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | PHAT | Grant (A) | — | $0 | EDGAR |